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Key Messages
1. Conservative voice therapy is 
the first choice of treatment 
for hyperfunctional voice 
problems.
2. Not all dysphonic patients will 
benefit from voice therapy.
3. A set of instrumental and 
perceptual variables that can be 
used to predict the outcome of 
therapy have been developed in 
this study.
Hong Kong Med J 2007;13(Suppl 5):S15-7
Introduction
Conservative (non-surgical) voice therapy is the typical choice of treatment for 
adults with laryngeal pathologies associated with hyperfunctional voice use. 
However, not all patients will benefit from conservative voice therapy as it 
involves behavioural changes that require cooperation of the patients.1 Owing 
to the high demand for conservative voice therapy in Hong Kong, selecting 
appropriate patients could ensure health care resources for this purpose are used 
cost-effectively.
Objectives
The primary objective of this study was to investigate how well two factors 
(severity of pathology and perception of activity limitation and/or participation 
restriction) can predict the outcome of conservative voice therapy. The study 
aimed to determine whether these two factors could be used as patient selection 
criteria for conservative voice therapy.
Methods
This project was conducted from November 1998 to December 2001, and 
consisted of two studies. The first was to develop an assessment tool for 
quantifying patient’s perception of the impact of voice disorders. The second 
was to investigate the efficacy of a voice therapy programme and the likelihood 
of predicting successful outcomes based on: (1) severity of pathology, and (2) 
perception of activity limitation and/or participation restriction.
Subjects
The first study involved 80 subjects (40 dysphonic with various laryngeal 
pathologies, 40 with normal voice). The second study involved 159 dysphonic 
subjects. However, due to attrition factor, only 80 female dysphonic subjects 
were included in the final analysis.
Study instruments
Study 1 involved designing a questionnaire and preliminary testing with 45 
dysphonic subjects and 10 speech therapists. It was further validated with 80 
dysphonic subjects. Study 2 involved acoustic, aerodynamic, and perceptual 
measurements with the questionnaire developed in study 1, to determine how 
well it could be used to predict the outcome of voice therapy.
Intervention
Study 2 involved an intervention voice programme, consisting of 10 weekly 
sessions. It entailed standard instructional procedures for all individuals. Subjects 
were randomly allocated to treatment or no-treatment group and all subjects were 
assessed before and after the intervention.
Main outcome measures
In study 2, acoustic measures, aerodynamic measures, perceptual ratings of 
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breathiness and roughness, and the Voice Activity and 
Participation Profile (VAPP) scores were used as the 
outcome parameters. Selected variables were used in the 
discriminant function analyses.
Results
Study 1 developed a validated assessment tool (VAPP) for 
documenting patient perception of voice activity limitation 
and participation restriction. The study found that subjects 
who were dysphonic perceived greater impacts than those 
with normal voices in the occupational domain, daily 
communication, social communication, and emotional 
aspect (Table 1). It also found that activity limitation and 
participation restriction could be affected separately. 
Specifically, this dissociation was found in the occupational 
domain, in which a subject might note limitation in activities 
but had no choice but to continue participating.
 In study 2, a conservative voice therapy programme was 
developed and shown to be effective in treating patients 
with hyperfunctional voice problems. Subjects who 
completed the programme showed significant improvement 
in jitter %, shimmer %, maximum fundamental frequency, 
fundamental frequency range (Table 2), all the VAPP 
scores excepting job domain (Table 3). They also showed 
Profile section Maximum score Mean (SD) activity limitation score Mean (SD) participation restriction score
Dysphonic group
Job 20 11.52 (5.38) 5.70 (6.04)
Daily communication 60 23.66 (13.37) 27.22 (14.21)
Social communication 20 6.28 (5.56) 6.19 (5.88)
Total 100 41.46 (19.95) 39.10 (23.20)
Control group
Job 20 1.19 (2.72) 0.54 (1.39)
Daily communication 60 4.45 (6.24) 2.53 (3.98)
Social communication 20 0.74 (1.80) 0.51 (1.08)
Total 100 6.38 (8.42) 3.57 (5.45)
Table 1. Activity limitation and participation restriction scores of the dysphonic and control groups
Acoustic measurements No. of 
subjects*
Mean SD Range Mean SD Range
Treatment group Pre-treatment Post-treatment 1
Maximum fundamental frequency (Hz) 42 723.00† 266.83 277.00-1568.00 912.80† 310.93 311.00-1568.00
Fundamental frequency range (semitone) 42 31.85† 90.20 13.00-48.00 37.18† 8.99 14.00-56.00
Jitter % 30 3.57† 1.23 1.59-6.46 2.89† 1.22 1.33-6.69
Shimmer % 30 9.56† 2.89 5.69-15.80 7.33† 2.23 4.23-14.35
No-treatment group Assessment 1 Assessment 2
Maximum fundamental frequency (Hz) 42 848.32 293.46 277.00-1319.00 825.28 207.15 440.00-1245.00
Fundamental frequency range (semitone) 42 34.89 10.76 3.00-56.00 35.07 6.88 24.00-50.00
Jitter % 34 3.35 1.16 1.64-6.86 3.41 1.29 1.70-6.24
Shimmer % 34 9.19 2.22 5.96-15.72 9.82 2.46 6.68-16.77
Table 2. Acoustic measurements in the treatment and no-treatment groups
* Group size varied for each measurement because the subjects produced some unanalysable aperiodic signals 
† Significant difference between pre-treatment and post-treatment 1, P<0.05
VAPP sections No. of subjects* Mean SD Range Mean SD Range
Treatment group Pre-treatment Post-treatment 1
Self-perceived severity 41 6.60† 1.89 2.20-9.60 3.68† 2.09 0.60-8.30
Job 41 15.21 11.66 0.00-35.30 12.71 9.98 0.00-35.40
Daily 41 62.17† 27.37 8.20-103.70 47.29† 22.77 6.40-91.30
Social 41 14.04† 11.79 0.00-35.70 9.10† 8.79 0.00-22.50
Emotion 41 33.15† 17.79 3.20-69.00 24.86† 17.81 2.00-64.90
Total activity limitation score 41 50.01† 22.74 5.70-85.20 35.23† 17.99 6.70-77.40
Total participation restriction score 41 43.33† 22.74 5.20-81.60 33.88† 19.35 5.50-79.90
Total VAPP 41 132.77† 57.72 20.90-245.30 97.66† 52.32 16.60-220.60
No treatment group Assessment 1 Assessment 2
Self-perceived severity 38 6.05 2.43 0.90-10.00 5.71 2.42 1.10-9.50
Job 38 16.95 10.07 0.00-37.40 17.91 10.56 0.00-36.60
Daily 38 57.14 29.69 0.00-115.00 60.33 31.88 0.00-112.80
Social 38 15.88 12.66 0.00-47.30 15.83 10.68 0.00-37.90
Emotion 38 37.03 19.08 0.20-6.70 36.21 21.16 0.00-65.40
Total activity limitation score 38 46.48 23.01 0.00-94.80 47.89 24.67 0.00-95.40
Total participation restriction score 38 43.49 24.28 0.00-86.20 46.18 25.90 0.00-91.20
Total VAPP 38 133.06 65.27 1.80-256.70 136.01 70.51 1.10-260.70
Table 3. Voice Activity and Participation Profile (VAPP) scores for the treatment and no-treatment groups
* Group size varied for each measurement because the subjects produced some unanalysable aperiodic signals
† Significant difference between pre-treatment and post-treatment 1, P<0.01
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Conservative voice therapy for laryngeal pathologies
Voice quality No. of subjects Treatment group No-treatment group t value P value
Mean SD Range Mean SD Range
Roughness 42 1.71 1.06 0.00-4.50 -1.73 1.25 -5.00 to 2.50 13.602 0.001†
Breathiness 42 1.79 1.68 1.50-5.00 -1.54 1.35 -4.50 to 1.50 10.005 0.001†
Overall severity 42 2.36 1.29 0.50-4.50 -1.89 1.38 -4.50 to 2.00 14.647 0.001†
Table 4. Change of perceptual voice quality for the treatment and no-treatment groups*
* Positive and negative values denote improvement and worsening of vocal quality, respectively
† Significant at 0.001 level (2-tailed)
improvement in all three perceptual voice qualities ratings 
(Table 4), in comparison to subjects who were given no 
treatment. Furthermore, three predictive variables (Pearson 
r at autocorrelation peak, mean flow rate for sentence 
production, noise-to-harmonic ratio and the total VAPP 
score) were all found to show high discriminative power in 
predicting changes in severity (perceptual breathiness) after 
treatment.
Discussion
The findings of this study have led to the development of 
an assessment battery that can be used to reliably predict 
the outcome of voice therapy. The battery consists of 
instrumental and perceptual analysis of the vocal pathology 
and condition, and a questionnaire surveying patients’ 
perception of disability and handicap caused by the vocal 
impairment. The assessment battery can be used as a clinical 
tool to select patients for conservative voice therapy. This 
tool will improve the accountability and cost-effectiveness 
of voice therapy.
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